Cat. No. 3119
Biological ActivityNicotinic receptor antagonist that displays selectivity for homomeric α7 and α9 receptors (IC50 values are 220 and 1800 nM respectively). Displays no effect on α2β2, α3β2, α4β2, α2β4, α3β3 and α4β4 subunit combinations.
Licensing InformationSold under license from University of Utah
(Modifications: Cys-12 = C-terminal amide, Disulfide bridge between 2 - 8, 3 - 12)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
McIntosh et al (1994) A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J.Biol.Chem. 269 16733. PMID: 8206995.
Johnson et al (1995) α-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric α7 and α9 receptors. Mol.Pharmacol. 48 194. PMID: 7651351.
Pereira et al (1996) α-Conotoxin-ImI: a competitive antagonist at α-Bungarotoxin-sensitive neuronal nicotinic receptors in hippocampal neurons. J.Pharmacol.Exp.Ther. 278 1472. PMID: 8819535.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: a-conotoxin ImI, supplier, α7, alpha7, a7, α9, alpha9, a9, selective, nAChR, antagonists, Nicotinic, Receptors, Acetylcholine, Non-Selective, Subtypes, Other, α-conotoxin, alpha-conotoxin, ImI, a-conotoxinImI, conotoxin
Find multiple products by catalog number
New Products in this Area
Meet your representative
October 15, 2013